In this context, ABCG2 is an ABC transporter; an inhibition of ABCG2 may reverse drug resistance of cancer cells, suggesting that miR-328 is a novel therapeutic approach for antimetastatic therapy [18]. Here, ABCG2 is linked to cancer.